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Abstract Pelizaeus-Merzbacher disease (PMD) is an X- 
linked recessive disorder that is characterized by dys- 
myelination of the central nervous system resulting from 
mutations in the proteolipid protein (PLP) gene. Muta­
tions causing either overexpression or expression of a
clinical expression in this patient, who was 35 years old, 
was relatively mild as the life expectancies of the conna- 
tal and classical forms of PMD do not normally extend 
beyond the first and second decade, respectively. Here, we 
describe another patient (II-1) who suffers from a mild
truncated form of PLP result in oligodendrocyte cell death form of this disorder and who is now 37 years old. 
because of accumulation of PLP in the endoplasmic retic­
ulum. It has therefore been hypothesized that absence of _____________________________________________
the protein should result in a less severe phenotype. How­
ever, until now, only one patient has been described with 
a complete deletion of the PLP gene. We report a Dutch 
family with a relatively mild form of PMD, in which the 
disease cosegregates with a (G-to-A) mutation in the initi­
ation codon of the PLP gene. This mutation should cause 
the total absence of PLP and is therefore in agreement 
with the hypothesis that absence of PLP leads to a mild 
form of PM D .
Introduction
Pelizaeus-Merzbacher disease (PMD) is an X-linked dys- 
myelinating disorder resulting from mutations in the pro­
teolipid protein (PLP) gene. Different mutations have 
been found in the PLP gene (Gow et al. 1994), mostly 
leading to the expression of altered or truncated forms of 
PLP, or to overexpression of the protein. One patient has 
been described with a deletion of at least 29 kb that in­
cludes the complete PLP gene (Raskind et al. 1991). The
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Case history
Motor dysfunction in patient I I -1 was first noticed at the age of 4  
years, A gradual retardation of motor and mental development re­
sulted in mental deficiency and spastic paraplegia. He was admit­
ted to an institution for the mentally disabled at age 14. At the age 
of 33 years, he came to medical attention again because of the slow 
deterioration o f  his mental condition and progression of his spastic 
tetraplegia. Neurologic evaluation revealed a spastic atactic tetra­
plegia. Cerebral fluid examination, metabolic screening, and en­
zyme activities of lysosomal enzymes showed no abnormalities. 
Electroencephalography (EEG) was normal, but cortical evoked 
potentials indicated slow central conduction velocities, Conduc­
tion velocities of the peripheral nerves were reduced, and magnetic 
resonance imaging (MRI) revealed extensive symmetric abnormal­
ities of the white matter, with signs of leukodystrophy. Sural nerve 
biopsy showed reduced density of myelinated fibers and groups of 
small myelinating fibers indicative of regeneration. No signs o f 
storage disease were found.
His sister (11-2) has an adequate mental function with intact co­
ordination and balance functions. However, she has a pyramidal 
syndrom e and com plains about pains in her muscles and joints. 
An M RI scan of her cervical m yelum  revealed an area o f  en ­
hanced signal intensity which might indicate a decrease in the 
amount of myelin.
This patient’s son (III-1) was bom  after an uneventful 42-week 
pregnancy. Delivery and the subsequent neonatal period were free 
o f  complications, but the baby was irritable and had sleeping prob­
lems in the first few weeks of life. A convergent strabismus was 
apparent, his motor development was retarded, and he was hypo­
tonic with a persistent headlag. An extension hypertonia gradually 
developed. At the age of 1 year, the child was alert and had good 
visual perception, but slightly atactic motor behavior was observed 
with an evident spastic tetraplegia and poor balance control. No 
abnormalities were revealed by laboratory investigations, includ­
ing karyotyping, hematological screening, liver and kidney func­
tion tests, metabolic screening, and determination of peroxisomal 
and lysosomal enzyme activities. EEG and visual and auditive 
evoked potentials were normal, somatosensory evoked potentials 
were retarded. The motor conduction velocities of peripheral
*m-
* #
»,
«
î. %
«f
* *
fl»*
m
VK*»
»
«>
j í í W
r': ■
«Mír”*"^«(*»<•
#: '
*
Mr
Wifc
|>IC»
H"v,
EfL «rá^r
yrtÿfcuato’ ■ 'i <
7J:, .'
HWH
<Wt«
iWt
'fr
«
MW».
W:
& ¿mir-
ft
ir'
\ 4?'
»
wit
#r
w*w ni
•SW'
w *t,i
Ujtfn fWgifWgrÿâ i ro If>ayp!gw>?d wmmm
<
'tiii,iè*ji*<Aftf.{&  ü  rj fìMJ tVìii «ikVWœiftfnfi
¿pMKlip’,r'
ÍM»
&
*>•
&W-
&
î n i i 44ü %.y ü 111 i g i
■f f f f 1 ^  /'Í 1 i,Ji cfLJ U&<cHji 'ciLi£
/  *
/ '  ■<■. 4 
X
í: '  ¿ v .
fi > %  
A 0 ,
u .  ß ri. .<: [ f -
fli'
fXÎ ÏÏV%ÏJ fez 'V$ iIK
ÿir%-i
i.alPjS’ f h ï € € :"Îa f i l  V-^| mé i: X. k vj 5 «Ë;® J: %J: Jk- ^ & •if'-'*
>% w•»¿•I:*» 'Ii
«*■'
il;
44 ;: î. 1
CMÌÌm? t,|. ■#■ lí
c® rrf^\ á3«J :,f ‘«s# £ %,. f%. \</ ^  t'f «e# <1 #•
.'-(••‘¿ /a
«wy Iv J*
:'"fe(■; &. f i ^ r i  f p i  ^  ir£ K teW'iii) ib  i f  i? « "  >.. iÿ  «;;•'<£■. r2:ßl.
yvW ^tK• /'
i —^ -
i ®. # W! «M
¡tifíi  ^:^r/%!t t"l' f / f:'# il l :% ..fe- I:^
x&f;
/7Í5',
I f  ^ "Ì CÍ!í ï l  i^  l f I ^  fà ci .1 í.% fe J t.J 11> 1ÄI 4,r!.<>m l ¡3 ¿- %. $ « :». ¡’■;. ill \<*#!'•■V*' 4 .  fi‘ " ' f4.. - J  /• / '%? Ú líI/ ' ^>^,^1 ' i ^ .y r® t f ■"■: ri I' ?. -
■'4r)hi¿\. l’ï ¿¥1
;. .'V/ \¡; ,4 "  ü  f , s  h
i "1 A¡ ¿‘ % Wr IJ ‘i I
I ^  hJ  I f. %¿Vi
I hj<Tf. Ù. '¡U-. <■.;■'yi.
r-¡
 ^  ^ |l .'jlWife .#■-■#& .,% Dftri c;.& &%,J Ci "% "I f :» f 11 % î  f  \t ¡ 3  1 Ciarli ^ 0  is.,# % J  % Â M  ., |, !,, J5j f6.-'"
I MJ'. ./ÂT ë f ¿ 1ü  I ‘Ü
Üÿ /«*£>;% s i r . t t*"À fî • “f %J %$- i, n^P
s , ) n 3 s r i
«
Wi
/% J c # / \U  Ú ^ - Á
ffo ,^t;¡,_ 4*4¡. ^  V f '"I A I I
V¿ •.-. :'• ',V Í '1 VÍ:.v!- IV
%(í,; 'i*,-: T: f*<11 ì-f.f. fem i t ?
%r% ^ t  f 17t î 4.^  L/ tê  i  I, j  i l  fe «ss! é % 1: I' -J -
ipmfyr 'P û î I' 1
t»
A I ^ iè; ^ '% îIT> ííg^  Í: '% wßiÄ'Qi J?'i ;% 1 \  ï f 4 : |^ :-§ |; .;  ^;:■ '4: l i>1'■%-1 . ' si.
ii5. I m f  I I I n  i ]fÍ i,# 'ÎsïA-Æ-ir-ii %J V*i ;i
111 ">!1* ¿ ic i  i. 1 ^
f 11"''\ i '1 j y  ï î î  T ■'% 4Mi- \.J!' I 4  î -fr U . fe ! 'C^  if 1«Í,
"• J=C 'Ji 15
r r  ifí- rífc -a-
1 i
ßi V  
!  1
íSc¡<:^ 0 .:,fe. ^
&
•
>k
¿"Y
:W 4 T'IIÎ¡: i,vÆ %\f %.,À
r^ . /•
o V
<*s
339
reticulum/GoIgi apparatus system, whereas in the absence 
of PLP, oligodendrocytes survive and make a PLP-lacking 
compact form of myelin (Gow et al, 1994; Kagawa et al.
1994). As the patients described in this report do not meet 
all the clinical criteria for the diagnosis of PMD, we con­
clude from these results that the clinical spectrum of X- 
linked PMD is wider than originally thought, with the 
practical implication that patients who do not meet all the 
clinical criteria should nevertheless be candidates for mu­
tation analysis of the PLP gene.
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